Cargando…

Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival

BACKGROUND: We aimed to investigate the interaction between CD133 and Nestin and further assessed the correlation of CD133 and Nestin with clinicopathological characteristics and survival in patients with astrocytic tumor. METHODS: Totally 127 patients with astrocytic tumor underwent surgical resect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qingping, Xu, Binchu, Chen, Jianliang, Chen, Furong, Chen, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083417/ https://www.ncbi.nlm.nih.gov/pubmed/31677196 http://dx.doi.org/10.1002/jcla.23082

Ejemplares similares

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
por: Veselska, Renata, et al.
Publicado: (2008)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
por: Zhang, Mingyu, et al.
Publicado: (2008)

FRAT1 Enhances the Proliferation and Tumorigenesis of CD133(+)Nestin(+) Glioma Stem Cells In Vitro and In Vivo
por: Guo, Geng, et al.
Publicado: (2020)

Astrocytes influence medulloblastoma phenotypes and CD133 surface expression
por: Gronseth, Emily, et al.
Publicado: (2020)

Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival
por: Korkolopoulou, P, et al.
Publicado: (2013)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

The Biological Role of Nestin((+))-Cells in Physiological and Pathological Cardiovascular Remodeling
por: Calderone, Angelino
Publicado: (2018)

Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis
por: Wu, Bin, et al.
Publicado: (2015)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

The Roles of MicroRNA-133 in Gynecological Tumors
por: Zhou, Yang, et al.
Publicado: (2022)

Significance of CD133 expression in esophageal squamous cell carcinoma
por: Okamoto, Hiroshi, et al.
Publicado: (2013)

Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
por: Ehteram, Hassan, et al.
Publicado: (2022)

Characterization of nestin expression in astrocytes in the rat hippocampal CA1 region following transient forebrain ischemia
por: Cho, Jeong Min, et al.
Publicado: (2013)

Aberrant expression of CD133 and CD82 in patients with pediatric acute lymphoblastic leukemia and the clinical significance
por: Ji, Hongyan, et al.
Publicado: (2017)

Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
por: Hongo, Kumiko, et al.
Publicado: (2012)

Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis
por: Zhang, Xinyi, et al.
Publicado: (2020)

The Nestin neural enhancer is essential for normal levels of endogenous Nestin in neuroprogenitors but is not required for embryo development
por: Thomson, Ella, et al.
Publicado: (2021)

Nestin Expression and the Survival of Patients With Digestive Tract Cancers: A Systematic Review and Meta-Analysis
por: Huang, Lumi, et al.
Publicado: (2023)

Superficial acral fibromyxoma on the tip of the big toe: expression of CD10 and nestin
por: Misago, N, et al.
Publicado: (2008)

Tenascin C Promotes Glioma Cell Malignant Behavior and Inhibits Chemosensitivity to Paclitaxel via Activation of the PI3K/AKT Signaling Pathway
por: Zhang, Qingping, et al.
Publicado: (2021)

Astrocytes in Alzheimer’s Disease: Pathological Significance and Molecular Pathways
por: Preman, Pranav, et al.
Publicado: (2021)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Prognostic significance of CD133 and ABCB5 expression in papillary thyroid carcinoma
por: Karas Zella, Maria Augusta, et al.
Publicado: (2020)

The Structural Function of Nestin in Cell Body Softening is Correlated with Cancer Cell Metastasis
por: Yamagishi, Ayana, et al.
Publicado: (2019)

A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma
por: Wang, Haiwei, et al.
Publicado: (2021)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Emerging biomarker in carcinogenesis. Focus on Nestin
por: Nowogrodzka, Katarzyna, et al.
Publicado: (2022)

CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy
por: Ke, Chien-Chih, et al.
Publicado: (2012)

Correlation Between Ki-67 Index, World Health Organization Grade and Patient Survival in Glial Tumors With Astrocytic Differentiation
por: Stoyanov, George S, et al.
Publicado: (2017)

CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: A systematic review and meta-analysis
por: Yiming, Li, et al.
Publicado: (2015)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Expression Profile of Stemness Markers CD138, Nestin and Alpha-SMA in Ameloblastic Tumours
por: Yiannis, Callisthenis, et al.
Publicado: (2021)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
por: Fan, Linni, et al.
Publicado: (2011)

CD133 in brain tumor: the prognostic factor
por: Li, Bin, et al.
Publicado: (2016)

Nestin-Cre Mice Are Affected by Hypopituitarism, Which Is Not Due to Significant Activity of the Transgene in the Pituitary Gland
por: Galichet, Christophe, et al.
Publicado: (2010)

The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma
por: Bai, Dou-Sheng, et al.
Publicado: (2017)

CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival
por: Chen, Haiyang, et al.
Publicado: (2013)

Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas
por: Mardani, Azam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8d54bpb0qfimispda3hgsasdh